CDK4/6 Inhibition Induces Senescence and Enhances Radiation Response by Disabling DNA Damage Repair in Oral Cavity Squamous Cell Carcinoma
Authors:
- Nitisha ShrivastavaNSNitisha Shrivastava
- Claudia Gutierrez ChavezCCClaudia Gutierrez Chavez
- Daniel LiDLDaniel Li
- Vikas MehtaVMVikas Mehta
- Carlos ThomasCTCarlos Thomas
- Cory D. FulcherCFCory D. Fulcher
- Nicole KawachiNKNicole Kawachi
- Danielle M. BottalicoDBDanielle M. Bottalico
- Michael B. PrystowskyMPMichael B. Prystowsky
- Indranil BasuIBIndranil Basu
- Chandan GuhaChandan Guha
- Thomas J. OwTOThomas J. Ow
Open Access
Abstract
Purpose: HPV(−) OCSCC resists radiation treatment. The CDKN2A gene, encoding p16INK4A, is commonly disrupted in OCSCC. p16 inhibits CDK4/CDK6, leading to cell cycle arrest, but the biological sequelae of CDK4/6 inhibition in OCSCC remains understudied. This study examines whether inhibition of CDK4/6 enhances radiation response in OCSCC. Methods: MTT assays were performed in OCSCC cell lines HN5 and CAL27 following treatment with palbociclib. Clonogenic survival and synergy were analyzed after radiation (RT-2 or 4Gy), palbociclib (P) (0.5 µM or 1 µM), or concurrent combination treatment (P+RT). DNA damage/repair and senescence were examined. CDK4/6 were targeted via siRNA to corroborate P+RT effects. Three-dimensional immortalized spheroids and organoids derived from patient tumors (conditionally reprogrammed OCSCC CR-06 and CR-18) were established to further examine and validate responses to P+RT. Results: P+RT demonstrated reduced viability and synergy, increased β-gal expression (~95%), and ~two-fold higher γH2AX. Rad51 and Ku80 were reduced after P+RT, indicating impairment of both HR and NHEJ. siCDK4/6 increased senescence with radiation. Spheroids showed reduced proliferation and size with P+RT. CR-06 and CR-18 further demonstrated three-fold reduced proliferation and organoids size with P+RT. Conclusion: Targeting CDK4/6 can lead to improved efficacy when combined with radiation in OCSCC by inducing senescence and inhibiting DNA damage repair.Keywords
Funding Information
- NIH-NIDCR (R03DE31001, NIH-NCI P30CA013330)
- Albert Einstein Cancer Center (R03DE31001, NIH-NCI P30CA013330)
This publication has 54 references indexed in Scilit:
- Molecular Pathways: Understanding the Role of Rad52 in Homologous Recombination for Therapeutic AdvancementClinical Cancer Research, 2012
- TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced SenescenceClinical Cancer Research, 2012
- Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor SitesClinical Cancer Research, 2011
- A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer CellsCancer Cell, 2011
- The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 2011
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1Science, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Therapy-Induced Senescence in CancerJNCI: Journal of the National Cancer Institute, 2010
- The human papillomavirus E7 oncoproteinVirology, 2009
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001